IP Library Granted Patent US 7,148,331
Granted Patent B2
US 7,148,331 · App. 10/924,785 · Granted Dec 12, 2006

Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,148,331
App. No.
10/924,785
Granted
Dec 12, 2006
Kind
B2
Abstract

The present invention provides amino acid sequences of polypeptides that are encoded by genes within the human genome, the dehydrogenase polypeptides of the present invention. The present invention specifically provides isolated polypeptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the dehydrogenase polypeptides, and methods of identifying modulators of the dehydrogenase polypeptides.

Claims (20)

1. An isolated antibody that selectively binds to a polypeptide, wherein the amino acid sequence of said polypeptide is SEQ ID NO:2.

2. An isolated antibody that selectively binds to a polypeptide, wherein the amino acid sequence of said polypeptide comprises SEQ ID NO:2.

3. The antibody of claim 1 , wherein the antibody is a monoclonal antibody.

4. The antibody of claim 2 , wherein the antibody is a monoclonal antibody.

5. The antibody of claim 1 , wherein the antibody is coupled to a detectable substance.

6. The antibody of claim 2 , wherein the antibody is coupled to a detectable substance.

7. The antibody of claim 3 , wherein the antibody is coupled to a detectable substance.

8. The antibody of claim 4 , wherein the antibody is coupled to a detectable substance.

9. A composition comprising the antibody of claim 1 and a pharmaceutically acceptable earner.

10. A composition comprising the antibody of claim 2 and a pharmaceutically acceptable carrier.

11. A composition comprising the antibody of claim 3 and a pharmaceutically acceptable carrier.

12. A composition comprising the antibody of claim 4 and a pharmaceutically acceptable carrier.

13. An isolated antibody fragment tat selectively binds to a polypeptide, wherein the amino acid sequence of said polypeptide consists of SEQ ID NO:2, and wherein the antibody fragment comprises a fragment selected from the group consisting of:

a) an Fab fragment;

b) an F(ab′) 2 fragment; and

c) an Fv fragment.

14. An isolated antibody fragment that selectively binds to a polypeptide, wherein the amino acid sequence of said polypeptide comprises SEQ ID NO:2, and wherein the antibody fragment comprises a fragment selected from the group consisting of:

a) an Fab fragment;

b) an F(ab′) 2 fragment; and

c) an Fv fragment.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →